FDA Investigator Natasha N Mccants
Natasha N Mccants has inspections in 11 countries as of 02 Nov 2023. Natasha N Mccants has collaborated with a combined 2738 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
309
Last Inspection Date:
02 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Italy,
United States of America,
Ireland,
France,
Switzerland,
Denmark,
Germany,
United Kingdom of Great Britain and Northern Ireland,
Canada,
Netherlands,
Brazil
Co-Investigator(s):
A Williams,
Abby Lmozeke Baker,
Abraham M Maekele,
Amanda K Willey,
Amy M Cramer,
Andrew Saunders,
Ann B Borromeo,
Ashleigh P Wodushek,
Ashley Patterson,
Barbara D Wright,
Barbara S Manson,
Barbara T Carmichael,
Benjamin W Anderson,
Bonnie E Conley,
Bonnie E Pierson,
Brandon C Heitmeier,
Brian S Lynch,
Carmen M Chan,
Carolyn E Barney,
Carter,
Casey L Hamblin,
Charles D Boison,
Charles N Dupont,
Cherie T Parker,
Cheryl D Mccall,
Cheryl G Scott,
Cheryl L Watson,
Christine M Parmentier,
Christophe L Boulmay,
Christopher J Adams,
Claire M Minden,
Claudette D Brooks,
Clendening,
Clifton C Francis,
Cody D Rickman,
Combs,
Cynthia L Medlin,
Cynthia R Gibson,
Dana M Klimavicz,
Danielle M Maddox,
Dannie E Rowland,
Daphne A Videau,
David J Gasparovich,
David R Heiar,
Dawn P Hall,
Debra A Taylor,
Decima L Washington,
Diane Hall,
Donna D Gallien, MPH,
Dyanthony T Jenkins,
Elias N Paz Alonzo,
Elizabeth D Connell,
Emily E Smith,
Erica M Katherine,
Erika M Wilkerson,
Ernest H Blackwood,
Evelyn Taha,
Francis A Guidry,
Frank Flores,
Gene D Arcy,
George J Flynn,
Habacuc V Barrera,
Harperd,
Herbert M Corbello,
Hultman,
James D Planchon,
James W Whitney,
Jamie P Webb,
Jason D Abel,
Javelle P Spann,
Jessica A Stephens,
John M Mcinnis,
Johnathan M Crayton,
Juanelma H Palmer,
Judy Ellen Ciaraldi,
June P Page,
Karen Gale Sego,
Kari L Batey,
Katrina B Mosley Sloan,
Kenneth R Merritt,
Kimberly L Mcmillan,
Kip J Hangs,
Kip J Hanks,
Konsuela Y Glass,
Lacey J Chessor,
Lakisha N Morton,
Larry A Estavan,
Laura E Garcia,
Laura L Staples,
LCDR Wilfred A Darang,
Leonard H Lavi,
Leslie F Sanders,
Linda Agregory Duty,
Lindsay H Bertling,
Lori A Carr,
Maressa L Mills,
Markeesa M Scales,
Marla A Cassidy,
Marquis S Allen,
Marshall H Kinsey,
Marvin D Jones,
Mary A Millner,
Matthew B Thomaston,
Matthew M Vernon,
Matthew R Mcnew,
Meihong Liu,
Melanie L Drayton,
Meredith L Sheridan,
Michael K Larson,
Mpris Inspector,
Myla T Collins,
Nadia V Simmons,
Nancy L Neiger,
Natalie A Guidry,
Nicholas M Smith,
Nicole Mccants,
Nikki S Bryant,
Oregan,
Pamela M Thomas,
Patricia S Smith,
Patrick C Dooley,
Pauline N Logan,
Peggy A Stogner,
Renee J Wilkes,
Richard J Bashay,
Richard T Riggie,
Robert E Hultman,
Roy Baby,
Samantha J Bradley,
Samuel L Collins,
Sandricka M Mosley,
Scott A Watson,
Shafiq S Ahadi,
Shannon Atlas,
Shayla G Turnipseed,
Shelton L Stribling,
Shondra N Gipson,
Sidney M Smith,
Smith,
State Agency,
Stephanie A Cochran,
Stephen D Eich,
Stephen G Mclane,
Steven D Dittert,
Suyang Qin,
Tammara D Perry,
Teresa Y Bills,
Thai T Duong,
Thomas B Smith,
Thomas O Morgan,
Thomas R Stanley,
Tony E Bable,
Traci M Armand,
Tracy J Washington,
Travis E Chapman,
Verlinda A Narcisse,
Wayne S Fortenberry,
Wendy R Blame,
Whitney M White,
Zada L Giles
Natasha N Mccants's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2009 | FDA 483 Response | Folsom Metal Products, Inc. - Form 483R, 2009-05-21 |
April, 2001 | FDA 483 | CARGILL INCORPORATED - Form 483, 2001-04-27 |
December, 2004 | FDA 483 | Health Science Products Inc - Form 483, 2004-12-08 |
February, 2009 | FDA 483 | Folsom Metal Products, Inc. - Form 483, 2009-02-23 |
April, 2009 | FDA 483 | Johnson Laboratories, Inc. - Form 483, 2009-04-23 |
March, 2018 | FDA 483 | Professional Specialties Co Inc - Form 483, 2018-03-02 |
August, 2000 | EIR | Capitol Vial - EIR, 2000-08-30 |
February, 2008 | FDA 483 | CHATTEM, INC. - Form 483, 2008-02-08 |
March, 2018 | EIR | Professional Specialties Co Inc - EIR, 2018-03-02 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more